Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124951382 | 12495138 | 2 | F | 20081204 | 20160802 | 20160624 | 20160804 | EXP | PHEH2016US015212 | NOVARTIS | 18.74 | YR | F | Y | 61.23000 | KG | 20160804 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124951382 | 12495138 | 1 | PS | TRILEPTAL | OXCARBAZEPINE | 1 | Unknown | UNK | 21014 | ||||||||||
124951382 | 12495138 | 2 | SS | OXCARBAZEPINE. | OXCARBAZEPINE | 1 | Oral | 750 MG, BID | Y | 21014 | 750 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124951382 | 12495138 | 1 | Product used for unknown indication |
124951382 | 12495138 | 2 | Seizure |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124951382 | 12495138 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124951382 | 12495138 | Dizziness | |
124951382 | 12495138 | Seizure | |
124951382 | 12495138 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124951382 | 12495138 | 2 | 200812 | 200812 | 0 |